))
Exploring New Frontiers in Blood Cancer Treatment
Manage episode 472501877 series 3331436
Content provided by UK FCS Extension. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by UK FCS Extension or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Host: Mindy McCulley, MS Family and Consumer Sciences Extension Specialist for Instructional Support, University of Kentucky
Guest: Dr. Gregory Monohan, MD, Professor, Division of Hematology and Blood Marrow Transplant, UK Markey Cancer Center
Cancer Conversations Episode 62
Dive into the latest episode of Cancer Conversation on Talking FACS, where host Mindy McCulley from the University of Kentucky Family and Consumer Sciences Extension is joined by Dr. Gregory Monohan, a professor of medicine in the Division of Hematology and Blood Marrow Transplant. In this insightful discussion, they explore groundbreaking advancements in the diagnosis and treatment of blood cancers, including leukemias, lymphomas, and multiple myeloma.
Dr. Monohan sheds light on the complexities of blood cancer classifications and the significant progress made in developing targeted therapies tailored to various subtypes. The episode highlights the pivotal role of immunotherapy, introducing CAR-T therapy, bispecific antibodies, and TIL therapy as cutting-edge approaches revolutionizing patient outcomes.
Listeners will gain a deeper understanding of the risk factors, symptoms, and innovative treatment methods that leverage the body's immune system to combat blood cancers. Whether you are a patient, a caregiver or simply curious about the latest cancer treatments, this episode offers valuable insights into the evolving landscape of blood cancer care.
Connect with the UK Markey Center
Online Markey Cancer Center
On Facebook @UKMarkey
On Twitter @UKMarkey
465 episodes
Share
